Stefan Lienenklaus Selected Research

Stefan Lienenklaus Research Topics

Disease

32	Infections 09/2023 - 04/2011
21	Neoplasms (Cancer) 09/2023 - 01/2007
11	Virus Diseases (Viral Diseases) 10/2023 - 07/2012
11	Inflammation (Inflammations) 01/2022 - 03/2014
6	Bites and Stings (Sting) 01/2023 - 02/2015
6	Bacterial Infections (Bacterial Infection) 01/2023 - 04/2011
3	COVID-19 07/2021 - 10/2020
3	Vesicular Stomatitis 01/2016 - 09/2014
2	Communicable Diseases (Infectious Diseases) 02/2021 - 01/2016
2	Neoplasm Metastasis (Metastasis) 01/2020 - 04/2010
2	Lymphoma (Lymphomas) 01/2020 - 10/2012
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020 - 01/2017
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2016 - 08/2013
1	Periodontitis 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2020
1	Cystic Fibrosis (Mucoviscidosis) 01/2019
1	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2018
1	Teratoma (Teratoid Tumor) 11/2018
1	Hepatitis 01/2018
1	Necrosis 01/2018
1	Reinfection 01/2017
1	Human Influenza (Influenza) 01/2017
1	Experimental Melanoma 11/2016
1	Osteitis 10/2016
1	Cognitive Dysfunction 04/2016
1	Splenomegaly 01/2016
1	Hepatocellular Carcinoma (Hepatoma) 01/2016

Drug/Important Bio-Agent (IBA)

20	Interferon Type IIBA 09/2023 - 08/2009
10	CytokinesIBA 01/2022 - 01/2007
8	VaccinesIBA 09/2023 - 11/2014
8	InterferonsIBA 01/2023 - 12/2013
7	Antiviral Agents (Antivirals)IBA 09/2023 - 09/2014
7	Proteins (Proteins, Gene)FDA Link 07/2021 - 04/2012
7	Interferon-betaIBA 10/2020 - 12/2007
6	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 02/2015
4	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 01/2022 - 03/2015
4	LuciferasesIBA 10/2020 - 10/2012
4	Firefly LuciferasesIBA 01/2019 - 10/2012
3	Messenger RNA (mRNA)IBA 01/2023 - 11/2016
3	A-Form DNA (A-DNA)IBA 01/2023 - 04/2012
3	Biocompatible Materials (Biomaterials)IBA 01/2022 - 09/2017
3	LipidsIBA 07/2021 - 10/2019
3	AntigensIBA 02/2021 - 01/2016
2	SARS-CoV-2 spike proteinIBA 10/2023 - 01/2021
2	TitaniumIBA 01/2023 - 10/2020
2	EnzymesIBA 01/2023 - 01/2016
2	Interleukin-17 (Interleukin 17)IBA 01/2022 - 10/2016
2	Peptides (Polypeptides)IBA 02/2021 - 01/2019
2	Subunit VaccinesIBA 02/2021 - 01/2017
2	Immunoglobulin G (IgG)IBA 01/2021 - 01/2017
2	poly(oxyethylene) cholesteryl etherIBA 01/2021 - 10/2020
2	NanogelsIBA 01/2021 - 01/2016
2	Toll-Like Receptor 7IBA 01/2021 - 01/2013
2	ElementsIBA 01/2020 - 01/2013
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2019 - 02/2015
2	Imiquimod (Aldara)FDA LinkGeneric 12/2018 - 01/2016
2	Interferon Receptors (Interferon Receptor)IBA 01/2018 - 04/2016
2	Pattern Recognition ReceptorsIBA 01/2016 - 01/2013
2	Therapeutic UsesIBA 04/2010 - 08/2009
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2009 - 08/2009
1	Poly I-CIBA 10/2023
1	IonsIBA 01/2023
1	SilverIBA 01/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2023
1	Nucleic AcidsIBA 01/2023
1	Tetracycline (Achromycin)FDA LinkGeneric 01/2023
1	EstersIBA 01/2021
1	AlbuminsIBA 01/2021
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2021
1	Viral ProteinsIBA 09/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	pembrolizumabIBA 01/2020
1	CXC ChemokinesIBA 01/2020
1	Death Domain ReceptorsIBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	PolymersIBA 10/2019
1	Blood Proteins (Serum Proteins)IBA 10/2019
1	Immunologic Factors (Immunomodulators)IBA 10/2019
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2019
1	NucleosidesIBA 11/2017
1	MagnesiumIBA 09/2017
1	vesicular stomatitis virus G proteinIBA 01/2017
1	Interleukin-22 (IL-22)IBA 10/2016
1	Interleukin-23 (Interleukin 23)IBA 10/2016
1	Poly A-UIBA 03/2016
1	Toll-Like Receptor AgonistsIBA 03/2016
1	Transcription Factors (Transcription Factor)IBA 01/2016
1	DNA VaccinesIBA 01/2016
1	Capsid Proteins (Capsid Protein)IBA 01/2016
1	RNA (Ribonucleic Acid)IBA 01/2016

Therapy/Procedure

9	Therapeutics 09/2023 - 08/2009
5	Immunotherapy 09/2023 - 03/2016
1	Intravenous Administration 01/2021
1	Cell- and Tissue-Based Therapy (Cell Therapy) 09/2020
1	Stem Cell Transplantation 01/2020
1	Hematopoietic Stem Cell Transplantation 01/2017
1	Liver Transplantation 01/2017